| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Kopernik Global Investors, LLC
|
5.243m | 9.13% | +661.200k | Apr 30 2026 |
| 2 |
Mykam Co.
|
5.178m | 9.01% | -384.000 | Sep 30 2025 |
| 3 |
Lucius Co., Ltd.
|
2.817m | 4.90% | -600.000 | Sep 30 2025 |
| 4 |
KYORIN Pharmaceutical Co., Ltd. Group Company
|
2.123m | 3.70% | +68.000k | Sep 30 2025 |
| 5 |
KK Achanzu
|
1.950m | 3.39% | — | Sep 30 2025 |
|
1
Kopernik Global Investors, LLC
|
9.13%
5.243m
|
|
2
Mykam Co.
|
9.01%
5.178m
|
|
3
Lucius Co., Ltd.
|
4.90%
2.817m
|
|
4
KYORIN Pharmaceutical Co., Ltd. Group Company
|
3.70%
2.123m
|
|
5
KK Achanzu
|
3.39%
1.950m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 30.13% of Kyorin Pharmaceutical Co.,ltd., with Kopernik Global Investors, LLC the biggest at 9.13%, followed by Mykam Co. (9.01%) and Lucius Co., Ltd. (4.90%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


